| Application no. and date | 10782040.9 (espacenet) (Federated) (European Patent Register), 20101101 | | Patent/reg. no. and date | DK/EP 2493498, 20170322 | | Publication date | 20120905 | | Priority no. and date | US 256905 P, 20091030 | | EP pub. no. and date |
EP 2493498 20120905 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals SA, Rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | 160516 | | Inventor | COSTANTINO, Paolo, Novartis Vaccines and Diagnostics Srl
Via Fiorentina 1
I-53100 Siena, IT,
ROMANO, Maria Rosaria, Novartis Vaccines and Diagnostics Srl
ViaFiorentina 1
I-53100 Siena, IT,
BERTI, Francesco, Novartis Vaccines and Diagnostics Srl
Via Fiorentina 1
I-53100 Siena, IT | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/085 (2006.01) , A61K 39/385 (2006.01) | | Title | Oprensning af Staphylococcus aureus type 5- og type 8 kapselsaccharider | | Int. application no. | IB2010054934 | | Int. publication no. | WO2011051917 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
